CD4 and COVID-19: Therefore, this study aimed to assess the antibody response following bivalent mRNA COVID-19 vaccine boosters in HIV-infected individuals with CD4 T lymphocyte counts ≤ 200 cells/mm3 compared to those with counts > 200 cells/mm3.